; (2) to maximize protections for human health and the environment; (3) to minimize costs for the production, use, and reclaiming of regulated substances; (4) to maximize flexibility for the recovery, reclaiming, and reuse of regulated substances; (5) to ensure consumer safety; (6) for the availability of substitutes, taking into account technological achievability, commercial demands, safety, and other relevant factors, including lead times for equipment conversion; and (7) to minimize any additional costs to consumers. (f) Evaluation In carrying out this section, the Administrator shall evaluate substitutes for regulated substances in a sector or subsector, taking into account technological achievability, commercial demands, safety, and other relevant factors. 11. International cooperation (a) In general Subject to subsection (b), no person subject to the requirements of this Act shall trade or transfer a production allowance or, after January 1, 2033, export a regulated substance to a person in a foreign country that, as determined by the Administrator, has not enacted or otherwise established within a reasonable timeframe after the date of enactment of this Act the same or similar requirements or otherwise undertaken commitments regarding the production and consumption of regulated substances as are contained in this Act. (b) Transfers Pursuant to subsection (a), a person in the United States may engage in a trade or transfer of a production allowance— (1) to a person in a foreign country if, at the time of the transfer, the Administrator revises the number of allowances for production under section 6(b), as applicable, for the United States such that the aggregate national production of the regulated substance to be traded under the revised production limits is equal to the least of— (A) the maximum production level permitted for the applicable regulated substance in the year of the transfer under this Act, less the production allowances transferred